Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism PKM2 stimulants(Pyruvate kinase isozymes M1/M2 stimulants) |
Active Indication |
Inactive Indication- |
Originator Organization Sitryx Therapeutics Ltd.Startup |
Active Organization Sitryx Therapeutics Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dermatitis, Atopic | Preclinical | GB | Sitryx Therapeutics Ltd.Startup | 13 Aug 2024 |